Harrow Quarterly Balance Sheet
NASDAQ: HROWHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Harrow financial position
As of Jun 30, 2026, Harrow reported total assets of $416.8 million, up 20.8% from a year earlier against total liabilities of $402.0 million. Shareholders' equity stood at $15.2 million, or 3.6% of assets. The company held $83.9 million in cash and equivalents against $292.4 million of debt, a net debt position of $208.5 million.
The current ratio (current assets divided by current liabilities) was 2.24, meaning short-term assets cover obligations due within a year. Debt-to-equity was 19.24.
Summary generated from market data by MetaCap's automated system. Methodology
Harrow balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 83.89M | 94.64M | 72.93M | 74.29M | 52.96M | 66.73M | 47.25M | 72.60M | 70.97M | 68.54M | 74.08M | 65.61M |
| Short-Term Investments | — | — | — | — | — | — | — | — | — | 7.43M | 8.68M | 8.27M |
| Receivables | 118.56M | 101.26M | 110.89M | 77.60M | 78.82M | 77.06M | 116.37M | 53.73M | 51.99M | 28.96M | 36.26M | 18.47M |
| Inventory | 16.91M | 16.50M | 13.52M | 12.83M | 11.55M | 10.72M | 10.70M | 10.16M | 9.43M | 10.81M | 10.87M | 8.92M |
| Total Current Assets | 229.31M | 226.38M | 211.75M | 177.60M | 154.89M | 169.53M | 189.65M | 147.06M | 139.39M | 125.46M | 139.48M | 110.28M |
| Property, Plant & Equipment | 2.96M | 3.13M | 3.26M | 3.38M | 3.51M | 3.57M | 3.73M | 3.63M | 3.29M | 3.39M | 3.52M | 3.63M |
| Goodwill | 332.00K | 332.00K | 332.00K | 332.00K | 332.00K | 332.00K | 332.00K | 332.00K | 332.00K | 332.00K | 332.00K | 332.00K |
| Intangible Assets | 175.57M | 181.05M | 175.17M | 172.46M | 176.67M | 180.76M | 184.95M | 189.27M | 154.88M | 157.37M | 159.91M | 162.70M |
| Total Assets | 416.82M | 419.54M | 399.48M | 363.07M | 345.03M | 364.16M | 388.97M | 351.54M | 306.63M | 295.54M | 312.16M | 286.06M |
| Accounts Payable | 26.27M | 26.13M | 35.35M | 18.99M | 23.41M | 37.09M | 38.76M | 25.28M | 22.26M | 15.13M | 24.58M | 12.77M |
| Total Current Liabilities | 102.17M | 91.44M | 96.30M | 65.40M | 248.88M | 186.99M | 91.34M | 95.00M | 53.55M | 41.75M | 49.34M | 19.03M |
| Long-Term Debt | 292.38M | 292.09M | 243.18M | 242.87M | 38.48M | 112.50M | 219.54M | 186.06M | 185.02M | 184.15M | 185.88M | 182.19M |
| Total Liabilities | 401.97M | 391.19M | 347.39M | 316.41M | 295.73M | 308.07M | 319.67M | 293.92M | 248.45M | 235.33M | 241.75M | 210.66M |
| Shareholders' Equity | 15.20M | 28.71M | 52.45M | 47.02M | 49.65M | 56.45M | 69.65M | 57.98M | 58.53M | 60.56M | 70.77M | 75.76M |
| Retained Earnings | -201.40M | -184.13M | -156.52M | -163.15M | -164.17M | -169.16M | -151.38M | -158.16M | -153.94M | -147.47M | -133.90M | -124.76M |
| Total Debt | 292.38M | 292.09M | 243.18M | 242.87M | 38.48M | 112.50M | 219.54M | 186.06M | 185.02M | 184.15M | 185.88M | 182.19M |
| Net Cash (Debt) | -208.49M | -197.44M | -170.26M | -168.58M | 14.48M | -45.77M | -172.29M | -113.46M | -114.06M | -108.18M | -103.12M | -108.31M |
| Shares Outstanding | 37.48M | 37.27M | 37.23M | 37.03M | 36.71M | 35.65M | 35.62M | 35.61M | 35.48M | 35.38M | 35.17M | 35.12M |
This table shows 12 quarterly periods of Harrow's balance sheet, from Q2 2026 back to Q3 2023, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow HROW's reporting calendar. What is a balance sheet?